Publications

Childhood brain tumors instruct cranial hematopoiesis and immunotolerance.

Authors: E Cooper, DA Posner, CYC Lee, L Hu, S Bonner, JT Taylor, O Baldwin, R Jimen...

E-pub date: 1 Feb 2026

Journal name: Nat Genet

ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer: final overall survival (OS) analysis

Authors: A Clamp, I Mcneish, D Radice, R Lord, A Michael, A Cook, R Agarwal, A Walth...

E-pub date: 1 Feb 2026

Journal name: International Journal of Gynecological Cancer

Optical coherence tomography and elastography for ex vivo visualization of early gastric cancer.

Authors: AG Gonzales, C Ruhland, G Spicer, S Mead, M Di Pietro, A Sanduka, PFS Rice,...

E-pub date: 1 Feb 2026

Journal name: J Biomed Opt

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

Authors: F Puddu, A Johansson, A Modat, J Scotcher, R Sethi, S Yu, N Harding, M Hill...

E-pub date: 20 Jan 2026

Journal name: Commun Med (Lond)

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Authors: A Watterson, G Picco, V Veninga, Y Samarakoon, CM Cattaneo, SF Vieira, E Ka...

E-pub date: 20 Jan 2026

Journal name: Cell Rep Med

Developing Predictive and Robust Radiomics Models for Chemotherapy Response in High-Grade Serous Ovarian Carcinoma

Authors: S Hatamikia, G George, F Schwarzhans, A Mahbod, MA Reinius, AA Ardakani, M ...

E-pub date: 13 Jan 2026

Journal name:

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.

Authors: G Mucciolo, G Biffi

E-pub date: 2 Jan 2026

Journal name: Cancer Res

Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer.

Authors: FLA Kwong, C Kristunas, C Davenport, J Deeks, S Mallett, R Agarwal, S Kehoe...

E-pub date: 1 Jan 2026

Journal name: Int J Gynecol Cancer

Filters

Research Groups

Core Facilities

Start date

End date

Childhood brain tumors instruct cranial hematopoiesis and immunotolerance.

ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer: final overall survival (OS) analysis

Optical coherence tomography and elastography for ex vivo visualization of early gastric cancer.

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Developing Predictive and Robust Radiomics Models for Chemotherapy Response in High-Grade Serous Ovarian Carcinoma

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.

Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Childhood brain tumors instruct cranial hematopoiesis and immunotolerance.

ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer: final overall survival (OS) analysis

Optical coherence tomography and elastography for ex vivo visualization of early gastric cancer.

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Developing Predictive and Robust Radiomics Models for Chemotherapy Response in High-Grade Serous Ovarian Carcinoma

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.

Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer.